Those of us who have large breed dogs such as Mastiffs, Great Dane, St. Bernard and the larger #Molosser breeds know the pain of losing them at 7-10 years old.
However, what if there was a way to extend the lifespan of these large-breed dogs? One company aims to do just that. The San Francisco-based startup Loyal is a clinical-stage veterinary medicine company that recently made headlines for working to receive conditional approval for a new medicine from the United States Food and Drug Administration (FDA). (Yep, the same government agency responsible for regulating human pharmaceuticals does the same for animals.)